Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
2.490
-0.010 (-0.40%)
Nov 18, 2026, 5:04 PM SGT
| Market Cap | 4.85B -18.5% |
| Revenue (ttm) | 888.15M -13.1% |
| Net Income | 170.51M -75.0% |
| EPS | 0.22 -75.0% |
| Shares Out | n/a |
| PE Ratio | 14.28 |
| Forward PE | n/a |
| Dividend | 0.89 (27.84%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 97,200 |
| Open | 2.500 |
| Previous Close | 2.500 |
| Day's Range | 2.490 - 2.510 |
| 52-Week Range | 2.450 - 3.750 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |